We screened by immunoblotting six breast cancer cell lines that are frequently used in molecular cancer research (HCC38, HCC1395, HCC1599, HCC1806, HCC1937, MDA-MB231), for possible deficiencies in the proteins of the MRE11-RAD50-NBN (MRN) complex. Here, RAD50 is linked to breast carcinoma.